Synthetic DNA products for UKHSA come from Twist Bioscience
- UK Health Security Agency
- London
- Direct award
- 22 September 2026 to 28 June 2029
The UK Health Security Agency (UKHSA) is buying synthetic DNA products from Twist Bioscience, made on the firm's own silicon-based DNA synthesis platform.
The range includes target enrichment panels and library preparation kits, as well as custom oligo pools and unique dual index adapters.
UKHSA awarded the £4.1m contract directly in July 2026. It runs for three years to June 2029, with two optional one-year extensions.
Contract ends June 2029
- What
- Genomic sequencing platforms and consumables
- Supplier
- Twist Bioscience
- Value
- £4.09m
- How it was bought
- Direct award
- Dates and next
- Sep 2026 to Jun 2029
- Option to Jun 2031